Beneficios de la ciproterona yo espironolactona para el tratamiento del hiperandrogenismo en pacientes con síndrome de ovario poliquístico. Una revisión narrativa

Abstract

Abstract: Polycystic ovary syndrome is one of the most common endocrinopathies in women. of childbearing age that encompasses clinical, psychological, dermatological and social problems in patients who suffer from it. Much of these problems are related to excess circulating androgen or hyperandrogenism of mainly ovarian origin. The management of this pathology encompasses different types of pharmacological agents, of which there are no Sufficient studies describing its possible beneficial or adverse effects. so the This work was developed with the aim of identifying the effectiveness and effects side effects of treatment of hyperandrogenism with cyproterone and/or spironolactone in PCOS patients. A search was carried out in the main databases, finding 17 articles for analysis. The results obtained demonstrated that a high effectiveness of these drugs for managing the symptoms of hyperandrogenism, however, insufficient evidence was found to support the presence of adverse effects, therefore that more studies focused on their analysis in these patients are recommended.